MCL-1, an anti-apoptotic BCL-2 family member that is essential for the survival of multiple cell lineages, is also among the most highly amplified genes in cancer. Although MCL-1 is known to oppose cell death, precisely how it functions to promote survival of normal and malignant cells is poorly understood. Here, we report that different forms of MCL-1 reside in distinct mitochondrial locations and exhibit separable functions. On the outer mitochondrial membrane, an MCL-1 isoform acts like other anti-apoptotic BCL-2 molecules to antagonize apoptosis, whereas an amino-terminally truncated isoform of MCL-1 that is imported into the mitochondrial matrix is necessary to facilitate normal mitochondrial fusion, ATP production, membrane potential, respiration, cristae ultrastructure and maintenance of oligomeric ATP synthase. Our results provide insight into how the surprisingly diverse salutary functions of MCL-1 may control the survival of both normal and cancer cells.
allow distribution to daughter cells during cell division 10, 11 . Imbalances in fission and fusion lead to a variety of cellular and mitochondrial defects 12, 13 . For example, mitochondrial fusion is required for cell growth, efficient oxidative phosphorylation and ATP production 10 . Thus, the integrity of the mitochondrial network is associated with cellular fate and bioenergetics.
MCL-1 is unique among pro-survival BCL-2 family members in that it is essential for embryonic development 14 and for the survival of multiple cell lineages in the adult, including lymphocytes 15, 16 , haematopoietic stem cells 17 , neutrophils 18, 19 and neurons 20 . Moreover, MCL-1 is frequently amplified in human cancers 21 and associated with chemotherapeutic resistance and relapse 22, 23 . Yet, how MCL-1 functions to promote survival of diverse normal and malignant cells remains poorly understood. Here, we reveal that MCL-1 is localized to distinct mitochondrial subcompartments with differential functions that affect mitochondrial activity and integrity. On the OMM, MCL-1 exerts its anti-apoptotic activity where it antagonizes BAX and BAK activation to maintain mitochondrial integrity. In contrast, MCL-1 localized to the mitochondrial matrix is unable to inhibit apoptosis, but maintains normal IMM structure, regulates fusion and promotes the assembly of ATP synthase oligomers; thereby, it 
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Wild-type shape factor of 1.0 indicates circular mitochondria and the higher the number, the more reticular the network. Error bars represent the s.e.m. from three independent experiments (n = 3) and statistical significance was determined by unpaired t -test ( * P < 0.01). (f) Quantification of mitochondrial cristae morphology from wild-type or Mcl-1-deficient MEFs. Mitochondria were counted from ∼100 individual cells and scored for normal (lamellar) or ballooned and swollen cristae (disorganized). Error bars indicate the s.e.m. from three independent experiments (n = 3).
(g) Enzymatic assays for indicated electron-transport-chain components from mouse liver mitochondria prepared from Mcl-1 f/f Mx1-Cre or wild-type Mx1-Cre mice 14 days after treatment with polyinosinic:polycytidylic acid (pI-pC). Three animals were assayed in triplicate from each of three independent experiments (n = 3) and error bars indicate the s.e.m. Statistical significance was determined by unpaired t -test ( * P < 0.01). Uncropped images of blots are shown in Supplementary Fig. S6 .
facilitates mitochondrial homeostasis and supports mitochondrial bioenergetic function.
RESULTS
Mcl-1 deletion results in mitochondrial morphology defects
We generated SV40-transformed wild-type or Fig. S1a ), but results in defective proliferation (Fig. 1b) . Notably, Mcl-1 deletion induces the appearance of punctate mitochondria and the loss of the tubular mitochondrial network present in control cells (Fig. 1c,d ). Furthermore, ultrastructural defects including defective cristae harbouring balloon-like, vesicular structures are apparent within most mitochondria in Mcl-1-deficient MEFs (Fig. 1e,f) . These abnormal cristae morphologies are not limited to transformed MEFs, as similar defects are observed in primary Mcl-1-deleted liver mitochondria ( Supplementary Fig. S1b ). Proteins involved in oxidative phosphorylation are enriched in the IMM (refs 24,25); therefore, we assessed whether Mcl-1 deletion alters the enzymatic activity of the respiratory chain complexes. Mcl-1 deletion in mouse liver mitochondria decreases the ability of NADH dehydrogenase (complex I), succinate dehydrogenase (complex II) and cytochrome c oxidase (complex IV) to transfer electrons; whereas pyruvate dehydrogenase (PDH) activity is unchanged (Fig. 1g) . Thus, loss of MCL-1 expression in MEFs and hepatocytes results in dysregulation of the reticular mitochondrial network, cristae morphological abnormalities and defects in electron-transportchain enzymatic function.
MCL-1 localizes to two distinct mitochondrial subcompartments
To understand the mechanisms underlying the dependence on MCL-1 for normal cristae morphology, we investigated the localization of MCL-1 within mitochondria. By immunoblot analysis, MCL-1 appears as a doublet or triplet in Percoll-purified liver mitochondria devoid of contaminating endoplasmic reticulum (Fig. 2a) . MCL-1 is a phosphorylated protein [26] [27] [28] ; however, phosphatase treatment does not abolish the 40,000 (40K) relative-molecular-mass (M r ) species (Supplementary Fig. S2a ). It has been proposed that non-canonical translational initiation at a non-ATG leads to the production of a faster-migrating M r 36K truncated protein 29 ; however, removal of the Fig. S2b ). It has also been proposed that non-canonical messenger RNA splicing generates the M r 36K species 30 ; however, ablation of the putative splice donor and acceptor still produces the doublet in cells (Supplementary Fig. S2c ). Thus, proteolytic cleavage is the most likely contributor to generating the M r 36K species 31, 32 . Indeed, Edman sequencing of MCL-1 detects two cleavage sites: between Ile 10 and Gly 11 and between Leu 33 and Val 34. Consequently, proteolysis of the N terminus of MCL-1 gives rise to three different MCL-1 species: full-length (M r 40K), cleaved at Ile 10 (M r 38K) and cleaved at Leu 33 (M r 36K).
The variant forms of MCL-1 exhibit different mitochondrial sublocalization; the M r 40K and M r 38K bands of MCL-1 are enriched in the OMM, whereas the M r 36K form is detected only in the mitoplast fraction, consisting of IMM and matrix (Fig. 2b) . Indeed, whereas both the M r 40K and M r 36K forms of MCL-1 are tightly associated with disrupted and alkali-washed mitochondrial membranes, the M r 38K species exhibits a looser association with membranes (Fig. 2c) . When mitochondria isolated from MEFs are treated with proteinase K, the M r 40K and M r 38K forms of MCL-1 are sensitive to protease digestion, but the M r 36K species remains resistant to degradation even after osmotic-shock-mediated permeabilization of the OMM (Fig. 2d) . Moreover, mitochondria from mouse liver and human non-small-cell lung cancer cell lines exhibit similar protease sensitivity, indicating that the submitochondrial localization of MCL-1 is evolutionarily conserved (Fig. 2e,f) . Immuno-electron microscopy of isolated liver mitochondria also indicates that endogenous MCL-1 localizes to both the OMM and IMM (Supplementary Fig. S3a ). Together, these results indicate that the M r 40K and M r 38K forms of MCL-1 reside on the outer leaflet of the OMM, whereas the M r 36K form is associated with the inner membrane and confined within the mitochondrial matrix.
During mitochondrial protein import, nuclear-encoded proteins are channelled into the mitochondria by the translocases of outer membrane (TOM) and inner membrane (TIM) proteins 33 . RNAmediated interference (RNAi) gene silencing of either TOM40 or TIM50 prevents the mitochondrial import of MCL-1, rendering it completely protease sensitive (Fig. 2g) . Accordingly, MCL-1 undergoes TOM-and TIM-dependent mitochondrial import.
MCL-1 possesses a mitochondrial targeting sequence
Both the N-and carboxy-terminal domains of MCL-1 are necessary for its proper mitochondrial localization and generation of a doublet by immunoblot analysis (Fig. 3a-c) . Proteins imported into the mitochondrial matrix often contain mitochondrial targeting sequences 33 (MTSs). To determine whether the N terminus of MCL-1 contains a MTS, the first 50 N-terminal amino acids of MCL-1 were fused to the N terminus of human BCL-2 (hBCL-2). hBCL-2 is normally restricted to the OMM; however, the chimaeric protein forms a doublet of which the faster migrating species appears in the matrix, thus validating that the N terminus of MCL-1 possesses a MTS (Fig. 3d) . Imported mitochondrial proteins often possess MTSs containing charged residues 33 . Mutagenesis of the arginine residues at positions 5 and 6 of MCL-1 to alanine (hereafter called MCL-1 OM ) maintains its localization to mitochondria, but abrogates the formation of the M r 36K form of MCL-1 (Fig. 3a,b,e) . Notably, MCL-1 OM is completely sensitive to proteolysis, indicating that the mutagenesis blocks mitochondrial import (Fig. 3f ). To generate a MCL-1 mutant that resides solely within the mitochondrial matrix, we fused the mitochondrial targeting sequence of matrix-localized ATP synthase 34 to N-truncated MCL-1 (hereafter called MCL-1 Matrix ; Fig. 3a ). MCL-1
Matrix localizes to mitochondria, and produces only a single protein species (Fig. 3b,e) . Moreover, MCL-1
Matrix is completely resistant to protease attack even under conditions of osmotic shock, illustrating that it localizes to the matrix (Fig. 3f) . Mcl-1 
Inhibition of cell death requires outer membrane-localized MCL-1
We assessed the anti-apoptotic activities of the different mitochondrial localized mutants of MCL-1. (Fig. 4b,c) . Furthermore, the expression of hBCL-2 in the Mcl-1-deleted MEFs renders cells resistant to death stimuli (Fig. 4b,c) . MCL-1 binds pro-apoptotic BH3-only molecules such as BIM, preventing OMM permeabilization and activation of the downstream apoptotic cascade 15 . Both the M r 40K species of wild-type MCL-1 and MCL-1 OM co-immunoprecipitate with pro-apoptotic BIM; however, no interaction is detectable between BIM and the M r 36K species of wild-type MCL-1 or between BIM and MCL-1 Matrix (Fig. 4d) . Thus, MCL-1 OM can bind pro-apoptotic modulators and prevent cell death similarly to wild-type MCL-1, but MCL-1
Matrix cannot sequester pro-apoptotic molecules or prevent apoptosis.
Matrix-localized MCL-1 is required for normal IMM structure and efficient mitochondrial fusion
Expression of either wild-type MCL-1 or MCL-1
Matrix in Mcl-1-deleted MEFs largely restores normal IMM structure, whereas MCL-1 OM does not (Fig. 5a,b) . We used photo-activatable GFP targeted to the matrix 35 to assess mitochondrial fusion. On Mcl-1 deletion, there is a delay in fusion that can be corrected by expression of either wild-type 
MCL-1 or MCL-1
Matrix but not by MCL-1 OM or hBCL-2 ( Fig. 5c,d ). Furthermore, expression of human MCL-1 ameliorates the delay in fusion and compensates for loss of mouse MCL-1, implying that this function is evolutionarily conserved (Supplementary Fig. S3b ). These data demonstrate that matrix-localized MCL-1 is necessary to promote normal IMM structure, mitochondrial fusion and maintenance of the mitochondrial reticular network.
Normal mitochondrial bioenergetics require matrix-localized MCL-1
Respiratory complexes pass electrons through the electron transport chain to reduce oxygen, thus generating a proton gradient that drives ATP production by the F 1 F 0 -ATP synthase; this process is called oxidative phosphorylation 36 . To stimulate oxidative phosphorylation, MEFs were cultured in glucose-free media supplemented with galactose 37, 38 . Under these conditions, Mcl-1 deletion reduces ATP levels, but expression of either wild-type MCL-1 or MCL-1 Matrix restores normal ATP levels (Fig. 6a) . In contrast, expression of either MCL-1 OM or hBCL-2 in the Mcl-1-deleted MEFs does not rescue ATP levels (Fig. 6a) . The proton gradient across the IMM drives ATP synthesis; therefore, we assessed whether the mitochondrial membrane potential was altered in cells lacking MCL-1. Indeed, Mcl-1 deletion decreases mitochondrial membrane potential, which is improved by expression of either wild-type MCL-1 or MCL-1
Matrix , but not MCL-1 OM ( Fig. 6b and Supplementary Fig. S4a ). Furthermore, Mcl-1-deleted MEFs also exhibit slower proliferation when compared with control cells (Supplementary Fig. S4b) . Expression of either wild-type MCL-1 or MCL-1
Matrix corrects the proliferative defect, whereas MCL-1 OM or hBCL-2 expression is unable to compensate for Mcl-1 deletion (Supplementary Fig. S4b ). Consequently, MEFs lacking matrix-localized MCL-1 generate less energy, have decreased mitochondrial membrane potential and grow poorly in galactosemedia even in the presence of anti-apoptotic MCL-1 on the OMM.
We determined whether respiration was altered by measuring oxygen consumption rates (OCRs) using the Seahorse XF24 analyser 39 . Mcl-1 deletion decreases both basal and maximal OCRs when compared with non-deleted MEFs (Fig. 6c,d and Supplementary  Fig. S5 ). Expression of either wild-type MCL-1 or MCL-1 Matrix restores the OCR; whereas neither MCL-1 OM nor hBCL-2 expression can restore the normal OCR (Fig. 6c,d and Supplementary Fig.  S5) or MCL-1
Matrix prevents the increase in superoxide production, consistent with their ability to rescue normal mitochondrial function ( Supplementary Fig. S4c ). In contrast, neither hBCL-2 nor MCL-1 OM can negate superoxide generation ( Supplementary  Fig. S4c ). Collectively, these data implicate that matrix-localized MCL-1 is required for optimal oxidative phosphorylation and prevention of superoxide in cells, a function that is separate from its anti-apoptotic role.
Mcl-1 is required for assembly of F 1 F 0 -ATP synthase oligomers
Structural and functional evidence has revealed that the individual electron-transport-chain complexes (I, II, III and IV) organize into intercomplex assemblies known as supercomplexes that are disrupted in the absence of one of their component complexes 40 . This supramolecular organization of the respiratory complexes has been proposed to increase the efficiency of electron transport and minimize the production of reactive oxygen species 40, 41 . Mcl-1 deletion does not affect the total protein expression of nuclear-encoded respiratory chain subunits; however, the protein levels of the mitochondrial DNA-encoded subunits of complex IV (Cox 1 and Cox 2) are decreased (Fig. 6e) . Therefore, we investigated whether the decreased Cox 1 and Cox 2 expression may be due to alterations in mitochondrial DNA (mtDNA). Indeed, Mcl-1-deletion decreases mtDNA content (Fig. 6f) . To investigate the structure of the respiratory complexes and supercomplexes, we used blue native polyacrylamide gel electrophoresis (BN-PAGE). Consistent with the loss of the Cox 1 and Cox 2 subunits Mx1-Cre (Mcl-1-deleted) or wild-type Mx1-Cre mice 14 days after treatment with pI-pC were lysed in digitonin and resolved by BN-PAGE and blotted to determine native complexes and supercomplexes (SC): complex I (CI, detected by NDUFA9), complex II (CII, detected by Fp70), complex III (CIII, detected by Core 2) and complex IV (CIV, detected by Cox I; g) and ATP synthase subunit F 0 B (5F1) and F 1 subunit beta (5B; h). The native migration of monomers, dimers and oligomers are denoted. Uncropped images of blots are shown in Supplementary Fig. S6 .
of complex IV, Mcl-1-deleted liver mitochondria also exhibit aberrant assembly of large supercomplexes (composed of complexes I, III and IV) as detected by Cox I (Fig. 6g) . These data are in agreement with the observations that the deletion of complex IV prevents the assembly of large supercomplexes 40, 42 . In contrast, the smaller respiratory supercomplexes seem relatively unaffected by Mcl-1 deletion (Fig. 6g) . Therefore, Mcl-1 deletion results in diminished mtDNA, reduced protein expression of Cox 1 and Cox 2 subunits and alterations in the large supercomplexes containing complexes I, III and IV.
The F 1 F 0 -ATP synthase also adopts supramolecular structures including the constitutive assembly of ATP synthase homo-dimers and higher-order homo-oligomers 43 . Furthermore, the assemblage into dimers and oligomers has been proffered as a determinant of the mitochondrial cristae structure and suggested to enhance efficiency of ATP synthesis [44] [45] [46] . As such, mutations that prevent the oligomerization of ATP synthase result in disorganized cristae membranes that form concentric circles and onion-like structures 47, 48 . By BN-PAGE, Mcl-1-deficient liver mitochondria possess less oligomeric ATP synthase and exhibit a corresponding increase in the monomer (Fig. 6h) . The lack of F 1 F 0 -ATP synthase oligomers is not due to loss of the individual subunits, implying that the defect is in the oligomerization of ATP synthase (Fig. 6e,h) . Accordingly, these data indicate that Mcl-1 is required for efficient assembly of F 1 F 0 -ATP synthase oligomers.
DISCUSSION
Gene-deletion studies have demonstrated that MCL-1 expression is critical to the survival of multiple cellular lineages, despite the concomitant expression of other pro-survival BCL-2 proteins 17,49-51 . However, the physiological reason why MCL-1 is essential for promoting the survival of so many different cell types remains elusive [14] [15] [16] [17] [18] [19] [20] . In this study, we reveal a role for MCL-1 in regulating mitochondrial inner membrane structure and function that is distinct from its ability to antagonize cell death. We demonstrate that cells express different isoforms of MCL-1 (M r 36K, M r 38K and M r 40K) that perform separate functions and localize to distinct mitochondrial sites. The M r 40K and M r 38K species of MCL-1 reside on the outer mitochondrial membrane where they antagonize pro-apoptotic molecules, thereby preventing cell death in a manner similar to other anti-apoptotic BCL-2 family members. During TOM-and TIM-dependent import, the N terminus of MCL-1 undergoes proteolytic processing resulting in a M r 36K species that is tethered to the IMM and exposed to the matrix. In the matrix, MCL-1 maintains normal IMM structure, fusion and maintenance of mitochondrial bioenergetics, but does not prevent apoptosis. Moreover, Mcl-1 is necessary to maintain normal mtDNA levels and mitochondrial-encoded proteins of complex IV. Depletion of mtDNA may be due to defective mitochondrial fusion because mitochondrial fusion is required for maintenance of mtDNA (ref. 52). Furthermore, it is possible that loss of the mitochondrial DNA-encoded Cox 1 and Cox 2 subunits of complex IV may lead to the de-stabilization or the aberrant assembly of the large supercomplexes containing complexes I, III and IV and may result in inefficient respiration. However, the underlying cause of the respiratory dysfunction is still unclear and will require further investigation.
Our data also indicate that MCL-1 is required for the proper assembly of the F 1 F 0 -ATP synthase into higher-order oligomers. The formation of F 1 F 0 -ATP synthase oligomers has been shown to be required for maintaining the proper organization of the IMM (refs 44,45) . Moreover, defects in mitochondrial cristae ultrastructure can result in the breakdown of the mitochondrial network 53 . Therefore, it is plausible that the loss of F 1 F 0 -ATP synthase oligomers in Mcl-1-deleted mitochondria may be responsible for the ultrastructural defects including disorganized cristae as well as the delay in mitochondrial fusion. To that end, identifying how MCL-1 promotes the maintenance of ATP synthase oligomers will be critical to understanding this function.
MCL-1 is a unique anti-apoptotic BCL-2 family member in that its genetic ablation results in cell-autonomous deficiencies in a myriad of cellular lineages [14] [15] [16] [17] [18] [19] [20] . However, MCL-1 gene ablation disables both its anti-apoptotic activity at the OMM as well as its ability to facilitate mitochondrial function within the matrix. For that reason, it will be important to determine the relative contributions of the different functional roles of MCL-1 for promoting the survival and development of haematopoietic and other cell lineages. The critical function of MCL-1 during these stages may merely be to support cell survival by antagonizing apoptosis. However, MCL-1 may also facilitate mitochondrial fitness during cellular proliferation and differentiation when metabolic demands on the mitochondria are modulated.
MCL-1 is one of the most highly amplified genes in a variety of human cancers 21 . As a result, most therapeutic strategies have been directed at antagonizing the anti-apoptotic activity of MCL-1, attempting to foster malignant cell death. However, these findings raise the possibility that the non-apoptotic function of MCL-1 may also fuel mitochondrial function in cancer cells, thus facilitating the generation of mitochondrially derived substrates required to maintain the levels of biomolecular synthesis that drives hyper-proliferation 54 . Therefore, inhibiting the ability of MCL-1 to promote mitochondrial function may represent a new therapeutic target in cancer cells.
METHODS
Methods and any associated references are available in the online version of the paper at www.nature.com/naturecellbiology 15, 55 . Mcl-1 f/f Rosa-ERCreT2 MEFs were generated from E12.5 embryos and SV40-transformed. To induce Cre-expression, MEFs were treated with 100 nM (4-hydroxy)-tamoxifen (Sigma) in media. HEK293T cells and human non-small-cell lung cancer cells were obtained from American Type Culture Collection. Cells were grown in Dulbecco's modified Eagle's medium (DMEM, Invitrogen) with 5% fetal bovine serum, 2 mM glutamine (Gibco) and 10 mM HEPES (Gibco). Cells grown in galactose were grown in glucose-free DMEM with 10% fetal bovine serum, 2 mM glutamine and 10 mM galactose. Ecotropic retroviral production and cell transduction. Retroviruses were produced by FuGene6 (Roche) co-transfection in HEK293T cells with packaging plasmids.
Plasmids
Subcellular fractionation and isolation of heavy membrane from cells. Cells
were swollen in 220 mM mannitol, 70 mM sucrose and 10 mM HEPES-KOH (pH 7.4) and homogenized with a 30-gauge needle. Non-lysed cells were sedimented at 600g and discarded. The supernatant was centrifuged at 5,500g and the pellet was the HM fraction. The supernatant was centrifuged at 100,000g and the soluble fraction was the cytosolic fraction.
Proteolysis of heavy-membrane fraction. HM were treated with the following treatments: proteinase K (0.2 mg ml −1 ), 20 mM KCl (osmotic shock), 1% SDS (membrane solubilization) on ice and precipitated with tricholoroacetic acid (Sigma).
Oxygen consumption. Respiration was measured 5 h after 64,000 cells per well were seeded using the XF24 analyser (Seahorse Bioscience) 39 . The OCR was measured sequentially after the addition of 0.5 µM oligomycin, 0.5 µM FCCP and 0.5 µM rotenone.
Alkali wash. Mitochondria were sonicated and centrifuged at 10,000g . The supernatant was centrifuged at 100,000g and the supernatant was the soluble fraction. The pellet was treated with 0.1 M sodium carbonate (pH 11.5) in mitoisolation buffer on ice and then centrifuged at 100,000g and supernatant and pellet were collected.
Mitochondria subfractionation. Mitochondria were swollen in 14 ml of 10 mM KH 2 PO 4 (pH 7.4). One-third volume of 1.8 M sucrose, 10 mM MgCl 2 was added to shrink the mitochondria. Mitochondria were sonicated and centrifuged at 12,000g to get supernatant 1 and pellet 1. Supernatant 1 was spun at 100,000g and pellet 2 was the OMM. Pellet 1 was resuspended in 7 ml of 1.8 M sucrose and 10 mM MgCl 2 on ice for 5 min and centrifuged at 5,500g and pellet 3 was the mitoplast. Cellular ATP. Assays were performed using the ATP Bioluminescence Assay Kit HSII (Roche) following the manufacturer's instructions. Luminescence was measured using a Biotek Synergy Luminometer and ATP concentration was determined by comparing values to a standard curve.
Image analysis. Images were captured using a Marianas spinning-disc confocal imaging system consisting of a Zeiss Axio Observer (Carl Zeiss MicroImaging) inverted microscope with a motorized stage, a CSU-X confocal head (Yokogawa Electric Corporation), a LaserStack laser launch and a Vector laser scanner head (Intelligent Imaging Innovations-3i) or a Zeiss Plan-Apochromat ×63, 1.4 NA oil objective and an Evolve 512 EMCCD camera (Photometrics). Fluorescence intensity was measured using Slidebook (Intelligent Imaging Innovations-3i).
Mitochondrial photo-activation fusion assay. Cells were transiently transfected with a photo-activatable GFP targeted to the mitochondrial matrix 35 . A region of interest (∼2 µm) of the mitochondria was activated using a 405 nm laser and time-lapse images were acquired. Total area of intensity (pixels above threshold) was normalized to the post-activation time point.
Analysis of mitochondrial morphology and shape. Cells were stably transfected with mito-DsRed (Clontech). A Laplacian two-dimensional spatial filter was applied to the maximum-intensity projection to highlight mitochondria and an intensity threshold applied to the images to mask mitochondrial objects. A shape factor consisting of p 2 /4πA (p = perimeter and A = area) was applied to mitochondria 56 .
Mitochondrial DNA isolation and quantification. Mcl-1
f/f Rosa-ERCreT2 or wild-type control MEFs were treated with tamoxifen (8 days) to induce deletion and quantification of relative copy number differences was carried out by analysing the difference in threshold amplification between mtDNA and nuclear DNA as previously described 52 . DNA was extracted using the DNeasy kit (Qiagen).
Mitochondrial membrane potential and image analysis. Cells were stained with 10 nM tetramethylrhodamine (Invitrogen) in Hank's balanced salt solution (Gibco) at 37 • C for 20 min. Imaging conditions (laser excitation power at 561 nm, exposure time and camera gain) were identical for all samples. Mean pixel-intensity values of mitochondria in the image were masked by a Ridler-Calvard automatic thresholding algorithm.
Transmission electron microscopy. Livers were fixed in 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer and post-fixed in 2% osmium tetroxide in 0.1 M sodium cacodylate buffer with 0.3% potassium ferrocyanide. Tissue was stained with 4% aqueous uranyl acetate, dehydrated, infiltrated and embedded in epoxy resin. Ultrathin sections (80 nm) were cut and imaged using a JEOL 1200 electron microscope with an AMT XR 111 camera.
Immuno-electron microscopy. Mitochondrial fractions were fixed for 2 h using a 4% paraformaldehyde in 0.1 M phosphate buffer, embedded in 12% gelatin, immersed in 2.3 M sucrose, frozen using liquid nitrogen and cryo-sectioned (85 nm) at a temperature of −110 • C using a Leica UCT ultramicrotome. The sections were labelled with anti-MCL-1 antibody (Abcam, clone Y37, ab32087) and 10 nm protein-A gold secondary (Cell Microscopy Center) as described previously 57 .
Immunofluorescence microscopy.
Mcl-1-deficient MEFs were transfected with
Mcl-1 constructs, labelled with MitoTracker red (Invitrogen) for 45 min at 37 • C, fixed in 4% paraformaldehyde and immunostained with anti-MCL-1 (Rockland) and Alexa488 anti-rabbit IgG (Invitrogen). Images were collected using a Leica DM IRBE microscope equipped with a Leica TCS Confocal System using ×63 magnification.
Enzymatic activity of electron-transport-chain components. The activity of NADH-ubiquinone oxidoreductase (complex I) was assayed as previously described 58 . Succinate-ubiquinone oxidoreductase (complex II) activity was assayed by measuring succinate-dependent reduction in 2,6-dichlorophenolindophenol (DCIP), mediated by CoQ 1 . The reaction was followed by recording absorbance at 600 nm following succinate addition 59 . Cytochrome c oxidase activity (complex IV) was assayed by measuring oxidation of cytochrome c at 550 nm and calculated using the extinction coefficient of 19.6 mM −1 cm −1 as previously described 60 . PDH activity was assayed by measuring pyruvate-dependent reduction of 2-(piodophenyl)-3-p-nitrophenyl-5-phenyltetrazolium chloride (INT), mediated by phenazine methosulphate (PMS), as previously described 61 .
Isolation of respiratory complexes and supercomplexes. Mitochondria were isolated as described previously 62 . Isolation of the complexes and supercomplexes was completed as previously described 40 .
BN-PAGE.
Mitochondrial lysates (20 µg) were resolved on 3-12% gradient BN-PAGE gel (Invitrogen) as previously described 40 . The gel was transferred onto PVDF and immunoblotted with the indicated antibodies. Sup. Fig. 3 Perciavalle et al. Figure S6 Full scans of immunoblot data. In many experiments, membranes were cut prior to probing each strip with a separate antibody. Crossed-lanes represent lanes that were not depicted in the main figure. The orientation of the samples is the same as in the main figure.
